What does CUSIP 20454B105 represent in this 13F holders report?

CUSIP 20454B105 is the security identifier for 20454B105 - COMPASS THERAPEUTICS INC - COM used to aggregate holder disclosures.

How many institutions held 20454B105 - COMPASS THERAPEUTICS INC - COM in Q2 2026?

No institutional holders were reported for 20454B105 - COMPASS THERAPEUTICS INC - COM in Q2 2026; review adjacent reporting periods for trend context.

COMPASS THERAPEUTICS INC - COM

CUSIP: 20454B105

Q2 2026 13F Holders as of 30 Jun 2026

Security type / class: Equity / COM
Total 13F shares: 0
Total 13F value: $0
Share change: -423,566
Number of holders: 0
Value change: -$2,240,664
Number of sells: 1

Security key

20454B105

Report period

Q2 2026

Institutions

Top holders

20454B105 full security history Previous quarter: Q1 2026

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 20454B105

Previous quarter: Q1 2026

Recent filing periods:

Q2 2026 Q1 2026

There are no holders of COMPASS THERAPEUTICS INC - COM as of Q2 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .